“Whereas CannabCo is totally centered on the applying of Purecann™ to the hashish trade, we couldn’t ignore the large alternative within the a lot bigger tobacco market” mentioned President and CEO Mark Pellicane.
The know-how, initially developed for the Medical Hashish Market and dubbed “PURECANN™”, was designed to eradicate the robust odour of smoking hashish with out dropping any of the product’s efficiency or properties. When the corporate was tasked with adapting the know-how with an eye fixed in direction of the tobacco trade the outcomes have been an astounding success. When requested in regards to the significance of making use of Purecann™ to tobacco, Frank Baldwin, CannabCo’s Director of Operations, commented: “To say that the distinctive odour related to cigarette smoking will not be a optimistic expertise is an understatement. Not less than this know-how permits a selection for a smoker to just about eradicate the scent and underlying social stigma related to the behavior”. Frank additional commented that, as with combusting hashish, the impact was noticed to be far cleaner and fewer harsh throughout the smoking course of.
The Purecann™ know-how nearly eliminates odour usually related to hashish each when packaged and saved prior to make use of, and in addition throughout the time it’s smoked. Given CannabCo’s current advances in making use of Purecann™ to tobacco, the identical can now be mentioned of cigarettes and the combustion of different tobacco merchandise. The corporate additional states that there aren’t any particular units required by the buyer for the dry hashish product or tobacco use.
Totally compliant with GMP requirements, the corporate intends to make the most of Purecann™ for the manufacturing of hashish merchandise distributed to the medical and leisure hashish markets. CannabCo additional intends to proceed the event of the know-how for licensing to the tobacco trade. “A smoker would be capable of go exterior for a break and return with out the tell-tale scent of cigarettes hooked up to their breath or clothes.” commented Pellicane.
“As a former smoker, I understand how a lot of an influence the scent would have on the individuals round me”.
Cannabco presently maintains full unique rights for the deployment of the know-how inclusive of use in each hashish and tobacco functions.
About CannabCo Pharmaceutical Corp.
CannabCo Pharmaceutical Corp. is a Canadian full-service hashish know-how firm with operations in Brampton, Ontario. The corporate has acquired its “Affirmation of Readiness” from Well being Canada to develop into a licensed producer and is presently constructing out its pilot facility within the Brampton Space. The corporate options all kinds of proprietary developed applied sciences together with PHOENIX for its cultivation initiatives claiming a excessive productiveness and considerably decrease price per gram than conventional grows. CannabCo is greatest identified for its Purecann™ know-how used for the manufacturing of Odourless Hashish™ and extra just lately Odourless Tobacco.
CannabCo’s pilot facility intends to pursue EU GMP standing permitting entry to the underserviced world pharmaceutical market.
Ahead Trying Statements
This press launch could include sure “forward-looking data” and “forward-looking statements” inside the which means of relevant securities laws. All data contained herein that’s not historic in nature could represent forward-looking data. Ahead-looking statements could also be recognized by statements containing the phrases “believes”, “anticipates”, “plans”, “intends”, “will”, “ought to”, “expects”, “proceed”, “estimate”, “forecasts” and different related expressions. Precise outcomes and developments could differ materially from these contemplated by these statements. Though CannabCo believes that the expectations mirrored in forward-looking statements on this press launch are cheap, there may be no assurance that such statements will show to be correct. Future occasions and outcomes may differ materially from these set forth in, contemplated by, or underlying the forward-looking statements on this press launch. Feedback and claims associated to PHOENIX and PURECANN™ are primarily based solely on that noticed and the opinions of administration in addition to third-party verifications supplied to CannabCo from trade consultants.
SOURCE CannabCo Pharmaceutical Corp.
For additional data: CannabCo Pharmaceutical Corp., [email protected], www.cannabco.ca